Targacept INC
SEC CIK 1124105 · TRGT · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Epstein David M. | Director | filed 2024 - 2026 |
| Carmichael Gordon | Director | filed 2023 - 2026 |
| Parry Renate | Director | filed 2023 - 2026 |
| Nussbaum Rodney L | Director | filed 2024 - 2026 |
| Zhang Ping | Director | filed 2025 - 2026 |
| Weng Dan | Director | filed 2025 - 2026 |
| Luo Ying | Director · Chief Executive Officer | filed 2023 - 2026 |
| Eastling Thomas Wilson | Director · Chief Financial Officer | filed 2023 - 2026 |
| Ma Songjiang | Director · President | filed 2023 - 2025 |
| Ying Han | Director · Chief Executive Officer | filed 2023 - 2024 |
| Usman Nassim | Director · President and CEO | filed 2015 - 2024 |
| Wu Charles C | Director · Chief Executive Officer | filed 2023 - 2023 |
| Lawlor Augustine | Director | filed 2015 - 2023 |
| Hunt Andrea | Director | filed 2017 - 2023 |
| Williams Eddie | Director | filed 2018 - 2022 |
| Ling Geoffrey M.D. | Director | filed 2020 - 2022 |
| Desouza Errol B | Director | filed 2006 - 2021 |
| JEW Jeanne Y | Director | filed 2021 - 2021 |
| Tetlow Sharon | Director | filed 2020 - 2021 |
| Richard John P | Director | filed 2006 - 2020 |
| Hill Stephen A | Director · President, CEO | filed 2012 - 2018 |
| Selick Harold E | Director | filed 2015 - 2018 |
| Himawan Jeff | Director | filed 2015 - 2015 |
| Brown Julia R | Director | filed 2007 - 2015 |
| Blixt Charles A | Director | filed 2006 - 2015 |
| Dunton Alan W | Director | filed 2006 - 2015 |
| Barrett M James | Director | filed 2006 - 2013 |
| Skaletsky Mark B | Director · Member, Office of the Chairman | filed 2006 - 2013 |
| Burrill Steven | Director | filed 2006 - 2012 |
| Snyderman Ralph | Director | filed 2007 - 2012 |
| Debethizy J Donald | Director · President and CEO | filed 2006 - 2012 |
| Jones Elaine V | Director | filed 2006 - 2008 |
| Hanham ANN | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ye Weiguo | Chief Operating Officer | filed 2023 - 2026 |
| Bergmann Joshua Benjamin | GC and Corporate Secretary | filed 2026 - 2026 |
| Xiong Yue | Chief Scientific Officer | filed 2026 - 2026 |
| Wang Jialiang (NMN) | EVP, General Manager | filed 2026 - 2026 |
| Chen Ruoyu | Interim CFO | filed 2023 - 2026 |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | filed 2021 - 2023 |
| Blouse Grant E. | Chief Scientific Officer | filed 2021 - 2022 |
| Levy Howard | Chief Medical Officer | filed 2016 - 2021 |
| Musil Clinton | Chief Financial Officer | filed 2020 - 2021 |
| Cai Veronica | Controller | filed 2020 - 2020 |
| Payne Fletcher | Chief Financial Officer | filed 2015 - 2019 |
| Madison Edwin | Chief Scientific Officer | filed 2015 - 2015 |
| Hodges Mauri K | VP, Fin. & Admin., CFO, Treas. | filed 2010 - 2015 |
| Rock Patrick C. | Secretary, GC | filed 2013 - 2015 |
| Musso Alan A | VP, CFO, Treasurer & Secretary | filed 2006 - 2014 |
| Toler Steven M. | VP, Trans Scnces & Emgng Opps | filed 2012 - 2014 |
| Hosford David A. | VP, Clin Dev & Reg Affairs | filed 2012 - 2014 |
| Bencherif Merouane | VP, Preclinical Research | filed 2006 - 2013 |
| Brennan Jeffrey P | VP - Bus. & Commercial Dev. | filed 2006 - 2013 |
| Zorn Peter A | VP, Lg Affrs, GC and Secrtary | filed 2006 - 2013 |
| Hicks Karen A | VP, Human Resources | filed 2010 - 2013 |
| Caldwell William S | VP - Drug Discovery and Dev. | filed 2006 - 2011 |
| Dunbar Geoffrey C | VP, Clin. Dev. & Reg. Affairs | filed 2006 - 2011 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.